Shepshelovich Daniel, Sherer Yaniv, Shoenfeld Yehuda
Department of Medicine B & Center for Autoimmune Diseases, Sheba Medical Center Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Harefuah. 2005 Aug;144(8):561-3, 598.
Cardiovascular manifestations are frequent in rheumatoid arthritis (RA) and significantly contribute to morbidity and mortality in this disorder. Premature atherosclerosis is responsible for these complications, as supported by autopsy studies. Moreover, a high prevalence of sub-clinical atherosclerosis--evaluated by imaging and instrumental parameters--has been reported. Traditional risk factors cannot completely account for accelerated atherosclerosis in RA. The presence of RA by itself and the immunosuppressive therapy (especially corticosteroids) represent non-traditional risk factors for premature atherosclerosis. Additional factors playing a synergistic role in the atherosclerotic process are systemic chronic inflammation frequently associated with RA and both humoral and cellular specific autoimmune responses. Herein we review and discuss atherosclerosis in rheumatoid arthritis, with special emphasis on clinical presentations, pathogenesis and therapy.
心血管表现在类风湿关节炎(RA)中很常见,并且在这种疾病的发病和死亡中起着重要作用。尸检研究表明,过早的动脉粥样硬化是这些并发症的原因。此外,通过影像学和仪器参数评估发现,亚临床动脉粥样硬化的患病率很高。传统危险因素不能完全解释RA中加速的动脉粥样硬化。RA本身的存在以及免疫抑制治疗(尤其是皮质类固醇)是过早动脉粥样硬化的非传统危险因素。在动脉粥样硬化过程中起协同作用的其他因素是经常与RA相关的全身性慢性炎症以及体液和细胞特异性自身免疫反应。在此,我们回顾并讨论类风湿关节炎中的动脉粥样硬化,特别强调临床表现、发病机制和治疗。